Literature DB >> 31486296

Plant molecular farming of virus-like nanoparticles as vaccines and reagents.

Edward P Rybicki1.   

Abstract

The use of plants for the production of virus-like nanoparticles (VNPs) dates back to separating natural empty capsids of plant viruses from whole virions nearly 70 years ago, through to the present use of transgenic plants or recombinant Agrobacterium tumefaciens and/or plant virus-derived vectors for the transient expression of engineered viral or other structural proteins in plants-a production system also known as molecular farming. Plant production of heterologous proteins has major advantages in terms of convenience-whole plants are generally used, and processes do not need to be sterile-and cost, as bulk biomass production is significantly cheaper than by any other method. Plant-made VNPs in current use for nanotechnology include whole virions and naturally occurring empty capsids of plant viruses, and particles made by reassembly of coat protein (CP) purified from virions or by recombinant expression. Engineered VNP-forming animal or human virus CPs expressed in plants include L1 protein from human papillomaviruses, human norovirus CP, hepatitis B surface and core antigens, influenza virus HA protein and HIV Gag polyprotein forming large enveloped particles by budding, orbi- and rotavirus particles that require assembly of four co-expressed proteins, and polio- and foot and mouth disease viruses which require proteolytic processing of a polyprotein precursor to form 4-component VNPs. Both plant and animal virus-derived plant-made VNPs can be used for surface and internal display of heterologous peptides or even whole proteins. A significant recent development has been the production of pseudovirions in plants, comprising plant or animal virus CPs and RNA or DNA pseudogenomes that can be used to deliver nucleic acid payloads into cultured cells or specific tissues or tumors in whole animals. This article is characterized under: Biology-Inspired Nanomaterials > Protein and Virus-Based Structures Therapeutic Approaches and Drug Discovery > Emerging Technologies Diagnostic Tools > in vivo Nanodiagnostics and Imaging.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  VLP; VNP; pseudovirion; virus-derived nanoparticle; virus-like particle

Year:  2019        PMID: 31486296     DOI: 10.1002/wnan.1587

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  24 in total

Review 1.  Nanotechnology-Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID-19 Vaccines.

Authors:  Chiara Rinoldi; Seyed Shahrooz Zargarian; Pawel Nakielski; Xiaoran Li; Anna Liguori; Francesca Petronella; Dario Presutti; Qiusheng Wang; Marco Costantini; Luciano De Sio; Chiara Gualandi; Bin Ding; Filippo Pierini
Journal:  Small Methods       Date:  2021-07-28

Review 2.  Optogenetic approaches in biotechnology and biomaterials.

Authors:  Vasily V Reshetnikov; Sviatlana V Smolskaya; Sofia G Feoktistova; Vladislav V Verkhusha
Journal:  Trends Biotechnol       Date:  2022-01-11       Impact factor: 21.942

Review 3.  The pharmacology of plant virus nanoparticles.

Authors:  Christian Isalomboto Nkanga; Nicole F Steinmetz
Journal:  Virology       Date:  2021-01-28       Impact factor: 3.616

4.  Turnip Mosaic Virus Coat Protein Deletion Mutants Allow Defining Dispensable Protein Domains for 'in Planta' eVLP Formation.

Authors:  Carmen Yuste-Calvo; Pablo Ibort; Flora Sánchez; Fernando Ponz
Journal:  Viruses       Date:  2020-06-19       Impact factor: 5.048

5.  Development of diagnostic tools for IBDV detection using plants as bioreactors.

Authors:  Evangelina Gómez; María Florencia Cassani; María Soledad Lucero; Viviana Parreño; Silvina Chimeno Zoth; Analía Berinstein
Journal:  AMB Express       Date:  2020-05-20       Impact factor: 3.298

6.  Will plant-made biopharmaceuticals play a role in the fight against COVID-19?

Authors:  Sergio Rosales-Mendoza
Journal:  Expert Opin Biol Ther       Date:  2020-04-13       Impact factor: 4.388

Review 7.  Innovation in plant-based transient protein expression for infectious disease prevention and preparedness.

Authors:  Frank Sainsbury
Journal:  Curr Opin Biotechnol       Date:  2019-12-06       Impact factor: 9.740

Review 8.  Recent Advances in the Use of Plant Virus-Like Particles as Vaccines.

Authors:  Ina Balke; Andris Zeltins
Journal:  Viruses       Date:  2020-02-28       Impact factor: 5.048

Review 9.  Potential Applications of Plant Biotechnology against SARS-CoV-2.

Authors:  Teresa Capell; Richard M Twyman; Victoria Armario-Najera; Julian K-C Ma; Stefan Schillberg; Paul Christou
Journal:  Trends Plant Sci       Date:  2020-04-24       Impact factor: 18.313

Review 10.  Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines.

Authors:  Kara-Lee Aves; Louise Goksøyr; Adam F Sander
Journal:  Viruses       Date:  2020-02-06       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.